| scholarly article | Q13442814 |
| P2093 | author name string | Huber R Warner | |
| P2860 | cites work | A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility | Q24532227 |
| Extension of chronological life span in yeast by decreased TOR pathway signaling | Q24539948 | ||
| Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice | Q24597354 | ||
| Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium-chain triglyceride oil on life span of genetically heterogeneous mice | Q24604312 | ||
| Rapamycin fed late in life extends lifespan in genetically heterogeneous mice | Q24647805 | ||
| An Aging Interventions Testing Program: study design and interim report | Q28213590 | ||
| Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction | Q28304066 | ||
| eRapa restores a normal life span in a FAP mouse model. | Q33760600 | ||
| Rapamycin slows aging in mice | Q34275079 | ||
| mTOR inhibition improves immune function in the elderly | Q34455680 | ||
| Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice | Q34796688 | ||
| Subfield history: use of model organisms in the search for human aging genes | Q35170161 | ||
| Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males | Q37638473 | ||
| Rapamycin joins the aging fray: maybe Ponce de Leon visited Rapa Nui, not Florida | Q43089927 | ||
| The role of mTOR signaling in controlling mammalian life span: what a fungicide teaches us about longevity | Q43190691 | ||
| Ageing: A midlife longevity drug? | Q45928202 | ||
| Biomedicine. A putative antiaging drug takes a step from mice to men. | Q46418325 | ||
| Pet dogs set to test anti-ageing drug. | Q55058637 | ||
| Program for testing biological interventions to promote healthy aging | Q74038421 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 22 | |
| P577 | publication date | 2015-03-01 | |
| P1433 | published in | Age | Q4691832 |
| P1476 | title | NIA's Intervention Testing Program at 10 years of age. | |
| P478 | volume | 37 |
| Q53770256 | A comprehensive approach to the molecular determinants of lifespan using a Boolean model of geroconversion. |
| Q30251783 | Age-Related Change in Mobility: Perspectives From Life Course Epidemiology and Geroscience |
| Q50149057 | Genetic cartography of longevity in humans and mice: Current landscape and horizons |
| Q26538688 | Impact of genetic background and experimental reproducibility on identifying chemical compounds with robust longevity effects |
| Q33825230 | Inhibition of NF-κB improves the stress resistance and myogenic differentiation of MDSPCs isolated from naturally aged mice |
| Q39494405 | Meta-Analysis of 29 Experiments Evaluating the Effects of Rapamycin on Life Span in the Laboratory Mouse |
| Q58773316 | Royal Jelly Delays Motor Functional Impairment During Aging in Genetically Heterogeneous Male Mice |
| Q38748528 | Sex differences in aging: genomic instability. |
| Q89937434 | The road ahead for health and lifespan interventions |
| Q38660086 | Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease. |
Search more.